2021年最新SCI期刊影响因子查询系统
EXPERT OPINION ON THERAPEUTIC TARGETS 期刊详细信息
基本信息
期刊名称 | EXPERT OPINION ON THERAPEUTIC TARGETS EXPERT OPINION ON THERAPEUTIC TARGETS |
---|---|
期刊ISSN | 1472-8222 |
期刊官方网站 | http://www.tandfonline.com/loi/iett20#.V48c20z9cSQ |
是否OA | 否 |
出版商 | Taylor and Francis Ltd. |
出版周期 | Monthly |
始发年份 | 2001 |
年文章数 | 77 |
最新影响因子 | 6.797(2021) |
中科院SCI期刊分区
大类学科 | 小类学科 | Top | 综述 |
---|---|---|---|
医学2区 | PHARMACOLOGY & PHARMACY 药学2区 | 否 | 是 |
CiteScore
CiteScore排名 | CiteScore | SJR | SNIP | ||
---|---|---|---|---|---|
学科 | 排名 | 百分位 | 4.13 | 1.470 | 1.021 |
Biochemistry, Genetics and Molecular Biology Clinical Biochemistry |
11 / 115 | 90% |
|||
Pharmacology, Toxicology and Pharmaceutics Drug Discovery |
21 / 146 | 85% |
|||
Biochemistry, Genetics and Molecular Biology Molecular Medicine |
34 / 165 | 79% |
|||
Pharmacology, Toxicology and Pharmaceutics Pharmacology |
39 / 300 | 87% |
补充信息
自引率 | 0.80% |
---|---|
H-index | 70 |
SCI收录状况 |
Science Citation Index Expanded |
官方审稿时间 | |
网友分享审稿时间 | 数据统计中,敬请期待。 |
PubMed Central (PML) | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1472-8222%5BISSN%5D |
投稿指南
期刊投稿网址 | https://mc.manuscriptcentral.com/eott |
---|---|
收稿范围 | Expert Opinion on Therapeutic Targets (ISSN 1472-8222 [print], 1744-7631 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles and original papers on novel molecular targets, providing expert opinion on the scope for future drug development and the impact on drug discovery. The journal evaluates molecules, signalling pathways, receptors and other therapeutic targets and their potential as candidates for drug development. Articles in this journal focus on the molecular level and early preclinical studies. Articles should not include clinical information including specific drugs and clinical trials. The Editors welcome: Reviews covering novel disease targets at the molecular level and information on early preclinical studies and their implications for future drug development. Articles should not include clinical information including specific drugs and clinical trials. Original research papers reporting results of target selection and validation studies and basic mechanism of action studies for investigative and marketed drugs. The audience consists of scientists, managers and decision makers in the pharmaceutical industry, academic researchers working in the field of molecular medicine and others closely involved in R&D. |
收录体裁 | |
投稿指南 | |
投稿模板 | |
参考文献格式 | |
编辑信息 |